Create Medicines raises $122M to bolster in vivo CAR-T therapies

Create Medicines has successfully raised $122 million to enhance its development of RNA-based CAR-T cell therapies aimed at treating cancer and autoimmune diseases. This funding will help advance their innovative pipeline, which focuses on in vivo applications of CAR-T technology.